Cytokinetics | CYTK - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Acadia Pharmaceuticals USD 31.5M 27.86M 2026-06
Amgen USD 2.38B 556M 2026-06
Arca Biopharma USD -31.82M 2.24M 2026-03
Bayer EUR 219M 2.54B 2026-06
Biogen USD 97.5M 222M 2026-06
Brainstorm Cell Therapeutics USD -2.13M 21K 2026-03
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Capricor Therapeutics USD -30.17M 5.6M 2025-12
Cytokinetics USD -198.76M 7.27M 2026-06
Eisai JPY 18.24B 21.49B 2026-06
Eli Lilly USD 7.1B 301M 2026-06
Exelixis USD 212.05M 1.58M 2026-06
Geron USD -3.64M 27.5M 2026-03
Halozyme Therapeutics USD 229.91M 79.86M 2026-06
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
Ligand Pharmaceuticals USD 48.51M 61.85M 2026-06
Merck USD -1.34B 2.9B 2026-06
Novartis USD 3.26B 108M 2026-06
Pfizer USD -248M 2.94B 2026-06
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sanofi EUR 343M 1.27B 2026-06